459 related articles for article (PubMed ID: 10854130)
1. Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway.
Chie L; Amar S; Kung HF; Lin MC; Chen H; Chung DL; Adler V; Ronai Z; Friedman FK; Robinson RC; Kovac C; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2000; 45(6):441-9. PubMed ID: 10854130
[TBL] [Abstract][Full Text] [Related]
2. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
3. Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus oocytes.
Qu Y; Adler V; Chu T; Platica O; Michl J; Pestka S; Izotova L; Boutjdir M; Pincus MR
Front Biosci; 2006 Sep; 11():2420-7. PubMed ID: 16720323
[TBL] [Abstract][Full Text] [Related]
4. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
Ranginwale M; Smith S; Flom J; Chie L; Kanovsky M; Chung D; Friedman FK; Robinson RC; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Exp Cell Res; 2001 Sep; 269(1):162-9. PubMed ID: 11525649
[TBL] [Abstract][Full Text] [Related]
5. Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase.
Villafania A; Anwar K; Amar S; Chie L; Way D; Chung DL; Adler V; Ronai Z; Brandt-Rauf PW; Yamaizumii Z; Kung HF; Pincus MR
Ann Clin Lab Sci; 2000 Jan; 30(1):57-64. PubMed ID: 10678584
[TBL] [Abstract][Full Text] [Related]
6. The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein.
Qu Y; Adler V; Izotova L; Pestka S; Bowne W; Michl J; Boutjdir M; Friedman FK; Pincus MR
Front Biosci; 2007 Sep; 12():5089-97. PubMed ID: 17569632
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents.
Amar S; Glozman A; Chung D; Adler V; Ronai Z; Friedman FK; Robinson R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
Cancer Chemother Pharmacol; 1997; 41(1):79-85. PubMed ID: 9443618
[TBL] [Abstract][Full Text] [Related]
8. Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.
Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
J Protein Chem; 1999 Nov; 18(8):881-4. PubMed ID: 10839625
[TBL] [Abstract][Full Text] [Related]
9. The 96 kDa protein kinase activated by oncogenic Ras in Xenopus egg extracts is also activated by constitutively active Mek: activation requires serine/threonine phosphorylation.
Pan BT; Zhang Y; Brott B; Chen DH
Oncogene; 1997 Apr; 14(14):1653-60. PubMed ID: 9135066
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase activation in Xenopus laevis eggs and embryos. A possible non-genomic role for the JNK signaling pathway.
Bagowski CP; Xiong W; Ferrell JE
J Biol Chem; 2001 Jan; 276(2):1459-65. PubMed ID: 11029471
[TBL] [Abstract][Full Text] [Related]
11. Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation.
Kovac C; Clie L; Morin J; Friedman FK; Robinson R; Chung DL; Kanovsky M; Flom J; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2001 Jul; 48(1):9-14. PubMed ID: 11488531
[TBL] [Abstract][Full Text] [Related]
12. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
Chesnel F; Bonnec G; Tardivel A; Boujard D
Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the ras-binding domain of the raf-p74 protein, identified from molecular dynamics calculations.
Chung D; Amar S; Glozman A; Chen JM; Friedman FK; Robinson R; Monaco R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
J Protein Chem; 1997 Aug; 16(6):631-5. PubMed ID: 9263125
[TBL] [Abstract][Full Text] [Related]
15. An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21.
Chie L; Adler V; Friedman FK; Chung D; Pincus MR
Protein J; 2004 Apr; 23(3):235-8. PubMed ID: 15200055
[TBL] [Abstract][Full Text] [Related]
16. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
18. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
Chie L; Cook JR; Chung D; Hoffmann R; Yang Z; Kim Y; Pestka S; Pincus MR
Ann Clin Lab Sci; 2003; 33(2):200-7. PubMed ID: 12817625
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Ras p21/mitogen-activated protein kinase signaling in vitro and in Xenopus oocytes.
Fukuda M; Gotoh Y; Kosako H; Hattori S; Nishida E
J Biol Chem; 1994 Dec; 269(52):33097-101. PubMed ID: 7806537
[TBL] [Abstract][Full Text] [Related]
20. Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptide.
Chie L; Friedman FK; Kung HF; Lin MC; Chung D; Pincus MR
J Protein Chem; 2002 Jul; 21(5):367-70. PubMed ID: 12206511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
